Concepedia

Publication | Open Access

Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

102

Citations

30

References

2013

Year

Abstract

Together, our results suggest that MK8776 selectively sensitizes HRR-proficient pancreatic cancer cells and xenografts to gemcitabine-radiation and support the clinical investigation of MK8776 in combination with gemcitabine-radiation in locally advanced pancreatic cancer.

References

YearCitations

Page 1